MindWalk Holdings (HYFT) Receivables - Net (2023 - 2026)
MindWalk Holdings (HYFT) reported Receivables - Net of $1.4 million for Q1 2026, down 46.58% year-over-year from $2.5 million in Q1 2025, and down 39.63% quarter-over-quarter from $2.2 million in Q4 2025.
MindWalk Holdings (HYFT) Receivables - Net (2023 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has 4 years of Receivables - Net data on file, last reported at $1.4 million in Q1 2026.
- Receivables - Net for Q1 2026 came in at $1.4 million, down 46.58% year-over-year; the trailing twelve-month figure through Jan 2026 was $1.4 million (down 46.58% YoY), and the FY2025 annual result was $3.0 million, up 5.68% from the prior year.
- Receivables - Net declined to $1.4 million in Q1 2026 per HYFT's latest filing, from $2.2 million in the prior quarter.
- Over five years, Receivables - Net peaked at $3.0 million in Q4 2024 and troughed at $1.3 million in Q3 2025.
- A 4-year average of $2.3 million and a median of $2.5 million in 2025 frame the typical range for Receivables - Net.
- The sharpest annual moves came in 2024 and 2026: Receivables - Net gained 16.48% in 2024, then slumped 46.58% in 2026.
- A 4-year view of Receivables - Net shows it stood at $2.7 million in 2023, then grew by 12.63% to $3.0 million in 2024, then fell by 25.21% to $2.2 million in 2025, then tumbled by 39.63% to $1.4 million in 2026.
- Business Quant data shows HYFT's Receivables - Net at $1.4 million in Q1 2026, $2.2 million in Q4 2025, and $1.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | MindWalk Holdings | 166.20 Mn | 156.06 Mn | 1.78 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 1.36 Mn |
| Jan 31, 2026 | 1.36 Mn |
| Oct 31, 2025 | 2.25 Mn |
| Oct 31, 2025 | 2.25 Mn |
| Jul 31, 2025 | 1.32 Mn |
| Jul 31, 2025 | 1.32 Mn |
| Apr 30, 2025 | 2.89 Mn |
| Apr 30, 2025 | 2.89 Mn |
| Jan 31, 2025 | 2.54 Mn |
| Jan 31, 2025 | 2.54 Mn |
| Oct 31, 2024 | 3.01 Mn |
| Oct 31, 2024 | 3.01 Mn |
| Jul 31, 2024 | 1.83 Mn |
| Jul 31, 2024 | 1.83 Mn |
| Apr 30, 2024 | 2.80 Mn |
| Apr 30, 2024 | 2.80 Mn |
| Jan 31, 2024 | 2.25 Mn |
| Jan 31, 2024 | 2.25 Mn |
| Oct 31, 2023 | 2.67 Mn |
| Oct 31, 2023 | 2.67 Mn |